Clinical Trials
14
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
- Conditions
- Heart TransplantImmunosuppressionAllograft
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- CareDx
- Target Recruit Count
- 930
- Registration Number
- NCT05459181
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
- Conditions
- Kidney TransplantAllograftImmunosuppression
- Interventions
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- CareDx
- Registration Number
- NCT05423496
AlloSure Lung Assessment and Metagenomics Outcomes Study
- Conditions
- Lung Transplant InfectionLung Transplant Failure and RejectionLung Transplant; Complications
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- CareDx
- Target Recruit Count
- 550
- Registration Number
- NCT05050955
- Locations
- 🇺🇸
University of Wisconsin Madison, Madison, Wisconsin, United States
🇺🇸University of Alabama (UAB), Birmingham, Alabama, United States
🇺🇸St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
- Conditions
- Transplant
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- CareDx
- Target Recruit Count
- 246
- Registration Number
- NCT05033548
- Locations
- 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
Molecular Assessment and Profiling of Liver Transplant Recipients
- Conditions
- Liver TransplantationBiomarkers
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- CareDx
- Target Recruit Count
- 1500
- Registration Number
- NCT04793360
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸Keck Medical Center of USC, Los Angeles, California, United States
🇺🇸MedStar Georgetown University Hospital, Washington, District of Columbia, United States
- Prev
- 1
- 2
- 3
- Next
News
CareDx Showcases Extensive Clinical Evidence for Transplant Monitoring Solutions at ISHLT 2025
CareDx presented 60 abstracts including 19 oral presentations at the 2025 ISHLT meeting, demonstrating the growing clinical adoption of their transplant monitoring solutions across 92 transplant centers.
CareDx Expands AlloSure Testing to Pediatric Heart and Simultaneous Pancreas-Kidney Transplant Patients
CareDx has received New York State Clinical Laboratory Evaluation Program approval for AlloSure testing in pediatric heart transplant patients of all ages, including infants, and in simultaneous pancreas-kidney transplant recipients.
CareDx's AlloSeq cfDNA Test Shows Strong Performance in Large European Kidney Transplant Study
A multicenter study of 580 kidney transplant patients demonstrates AlloSeq cfDNA's high accuracy in detecting allograft rejection, achieving an AUC of 0.758.
CareDx's AlloHeme Test Shows 93% Sensitivity in Early Detection of AML and MDS Relapse Post-Transplant
Interim results from the ACROBAT study demonstrate AlloHeme's superior accuracy in detecting post-transplant relapse in AML and MDS patients, with 93% sensitivity and 88% specificity.
CareDx and TC BioPharm Partner to Enhance AlloCell Monitoring in AML Trial
CareDx partners with TC BioPharm to perform pharmacokinetic analysis in the ACHIEVE clinical trial using its AlloCell solution.